Skip to main content
. 2010 Aug 26;4:170. doi: 10.3389/fnhum.2010.00170

Figure 3.

Figure 3

Adaptive-tracking performance, saccadic peak velocity and pupil–iris ratio pre-treatment and post-treatment, separately for each treatment group (error bars indicate standard errors of the mean). PLA, placebo; CIT, citalopram; RBX, reboxetine.